TY - JOUR
T1 - Direct interactions between the heterotrimeric G protein subunit Gβ5 and the G protein γ subunit-like domain-containing regulator of G protein signaling 11
T2 - Gain of function of cyan fluorescent protein-tagged Gγ3
AU - Zhou, Janice Y.
AU - Toth, Peter T.
AU - Miller, Richard J.
PY - 2003/5/1
Y1 - 2003/5/1
N2 - We used fluorescence resonance energy transfer imaging of enhanced cyan fluorescent protein (CFP)-tagged and enhanced yellow fluorescent protein (YFP)-tagged protein pairs to examine the hypothesis that G protein γ subunit-like (GGL) domain-containing regulators of G protein signaling (RGS) can directly bind to the Gβ5 subunit of heterotrimeric G proteins in vivo. We observed that Gβ5 could interact with Gγ2 and Gγ13, after their expression in human embryonic kidney 293 cells. Interestingly, although untagged Gγ3 did not interact with Gβ5, CFP-tagged Gγ3 strongly interacted with YFP-tagged Gβ5 in FRET studies. Moreover, CFP-Gγ3 supported Ca2+ channel inhibition when paired with Gβ5 or YFP-Gβ5, indicating a "gain of function" for CFP-Gγ3. Gβ5 could also interact with RGS11 and its N-terminal, but not its C-terminal domain. On the other hand, RGS11 did not interact with Gβ1. These studies demonstrate that the GGL domain-containing N terminus of RGS11 can directly interact with Gβ5 in vivo and supports the hypothesis that this interaction may contribute to the specificity of Gβ5 interactions with cellular effector molecules.
AB - We used fluorescence resonance energy transfer imaging of enhanced cyan fluorescent protein (CFP)-tagged and enhanced yellow fluorescent protein (YFP)-tagged protein pairs to examine the hypothesis that G protein γ subunit-like (GGL) domain-containing regulators of G protein signaling (RGS) can directly bind to the Gβ5 subunit of heterotrimeric G proteins in vivo. We observed that Gβ5 could interact with Gγ2 and Gγ13, after their expression in human embryonic kidney 293 cells. Interestingly, although untagged Gγ3 did not interact with Gβ5, CFP-tagged Gγ3 strongly interacted with YFP-tagged Gβ5 in FRET studies. Moreover, CFP-Gγ3 supported Ca2+ channel inhibition when paired with Gβ5 or YFP-Gβ5, indicating a "gain of function" for CFP-Gγ3. Gβ5 could also interact with RGS11 and its N-terminal, but not its C-terminal domain. On the other hand, RGS11 did not interact with Gβ1. These studies demonstrate that the GGL domain-containing N terminus of RGS11 can directly interact with Gβ5 in vivo and supports the hypothesis that this interaction may contribute to the specificity of Gβ5 interactions with cellular effector molecules.
UR - http://www.scopus.com/inward/record.url?scp=0037404433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037404433&partnerID=8YFLogxK
U2 - 10.1124/jpet.102.048637
DO - 10.1124/jpet.102.048637
M3 - Article
C2 - 12606627
AN - SCOPUS:0037404433
SN - 0022-3565
VL - 305
SP - 460
EP - 466
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -